Cite
HARVARD Citation
Wei, J. et al. (2017). Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52‐week pooled results from two phase 3 studies. International journal of rheumatic diseases. pp. 589-596. [Online].